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Accumulating evidence demonstrates that CD8+ T cells contribute to protection from severe
dengue virus (DENV) disease and vaccine efficacy. Nevertheless, molecular programs
associated with DENV-specific CD8+ T cell subsets have not been defined. Here, we
studied the transcriptomic profiles of human DENV-specific CD8+ T cells isolated after
stimulation with DENV epitopes from donors who had been infected with DENV multiple
times and would therefore be expected to have significant levels of adaptive immunity. We
found that DENV-specific CD8+ T cells mainly consisted of effector memory subsets,
namely CD45RA−CCR7− effector memory (Tem) and CD45RA+CCR7− effector memory re-
expressing CD45RA (Temra) cells, which enacted specific gene expression profiles upon
stimulation with cognate antigens. DENV-specific CD8+ T cell subsets in general, and
Temra cells in particular, were fully activated and polyfunctional, yet associated with
relatively narrow transcriptional responses. Furthermore, we found that DENV-specific
CD8+ Tem and Temra cells showed some unique T cell receptor features in terms of
overlap and variable (V) gene usage. This study provides a transcriptomic definition of
DENV-specific activated human CD8+ T cell subsets and defines a benchmark profile that
vaccine-specific responses could aim to reproduce.
Research Article Immunology Infectious disease
Find the latest version:
http://jci.me/123726/pdf
The Journal of Clinical Investigation   R E S E A R C H  A R T I C L E
1jci.org
Introduction
Dengue virus (DENV) infection is a serious public health problem 
in tropical and subtropical areas, and it is estimated that approx-
imately 390 million people are infected yearly (1). DENV infec-
tion is associated with a range of clinical manifestations, from 
asymptomatic to life-threatening. More severe dengue disease 
presentations including dengue hemorrhagic fever and dengue 
shock syndrome are usually associated with heterotypic second-
ary infections with one of the four different serotypes (DENV1–
DENV4) (2), which is postulated to be at least partially mediated 
by non-neutralizing serotype cross-reactive antibodies that can 
lead to antibody-dependent enhancement of infection (3–5).
The role of CD8+ T cells in dengue infection has been the sub-
ject of intense debate. Although some initial studies postulated 
that T cells may exacerbate the development of dengue diseases, 
subsequent studies indicate that T cells may have protective func-
tions (6–8). CD8+ T cells have been shown to mediate protection 
in murine models of DENV infection and vaccination (9–12), and 
CD8+ T cells can confer protection against heterotypic DENV 
infection and prevent antibody-dependent enhancement (13–15). 
In humans, DENV-specific CD8+ T cells can migrate to the skin, 
and their frequency may be inversely correlated with disease 
severity (16, 17). Notably, high-magnitude and polyfunctional 
DENV-specific CD8+ T cell responses are associated with pro-
tective HLA alleles against severe dengue disease in the general 
populations of Sri Lanka and Nicaragua, where DENV infection 
is highly endemic (18, 19). The recently approved Dengvaxia vac-
cine was designed to induce humoral but not CD8+ T cell respons-
es against DENV. However, its suboptimal efficacy, coupled with 
safety adverse events, signals that the need for an efficacious 
DENV vaccine is still unmet. Most importantly, these issues urge 
a better understanding of DENV-specific CD8+ T cell responses at 
the cellular and molecular levels.
Surprisingly, the phenotypic and transcriptomic profiles of 
isolated human DENV-specific CD8+ T cell subsets have not yet 
been systematically interrogated. Some information exists relat-
ed to the transcriptional signatures of whole blood and PBMCs 
in DENV-infected patients (23–26); however, much less is known 
at the level of human T cells. Although transcriptomic analyses 
of human CD8+ T cells from DENV-infected patients have been 
conducted, in those studies the gene expression profiles were ana-
lyzed not at the level of antigen-specific CD8+ T cells, but at the 
level of activated CD8+ T cell populations (27). Furthermore, little 
information exists at the level of CD8+ T cell subsets, such as Tcm, 
Tem, and Temra cells. This is particularly relevant as CD8+ Temra 
cells have been implicated in protection from viral pathogens such 
as HIV, cytomegalovirus (CMV), Epstein-Barr virus (EBV), influ-
enza virus, and yellow fever virus in humans (28–32). Thus, it is 
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T cells, the vast majority of IFN-γ+ CD8+ T cells in the DENV 
megapool–stimulated group displayed either a CD45RA–CCR7– 
effector memory T (Tem) or a CD45RA+CCR7– effector memory 
T re-expressing CD45RA (Temra) phenotype (Figure 1C), also 
consistent with a previous report (19). To further confirm the Tem 
and Temra phenotype of DENV-specific CD8+ T cells without 
peptide stimulation, we used a previously defined pool of eight 
HLA-B*35:01 tetramers incorporating 8 different HLA-B*35:01–
restricted DENV epitopes (19). Consistent with the phenotype of 
DENV IFN-γ+ cells, the majority of HLA-B*35:01 tetramer–posi-
tive CD8+ T cells displayed a Tem or Temra phenotype (Supple-
mental Figure 1; supplemental material available online with 
this article; https://doi.org/10.1172/JCI123726DS1) in tested 
HLA-matched donors. Thus, these results demonstrate that the 
frequency of anti-DENV CD8+ T cells varies between individuals, 
and that DENV-specific CD8+ T cells are primarily composed of 
Tem and Temra cells.
Gene expression profiles of unstimulated and DENV IFN-γ+ CD8+ 
Tem and Temra cells. Since DENV-specific CD8+ T cells were pre-
dominantly Tem and Temra cells as shown in Figure 1, we next 
isolated DENV IFN-γ+ CD8+ Tem and Temra cells and studied 
their immune signatures by bulk RNA sequencing (RNA-Seq). As 
a control, we also performed RNA-Seq on sorted IFN-γ– CD8+ Tem 
and Temra cells from unstimulated PBMCs. We then performed 
principal component analysis to visualize the global gene expres-
sion patterns of these various CD8+ T cell subsets. As expected, 
unstimulated CD8+ Tem and Temra cells were separated and 
formed distinct clusters. In contrast, DENV IFN-γ+ CD8+ Tem and 
Temra cells were grouped together, forming a distinct cluster that 
was well separated from unstimulated CD8+ Tem and Temra cells 
(Figure 2A). Thus, the gene expression signatures of DENV IFN-γ+ 
CD8+ Tem and Temra cells are clearly different from those of their 
unstimulated counterparts.
Next, we performed pairwise analyses to identify differentially 
expressed (DE) genes between the different sorted T cell subsets, 
namely stimulated DENV IFN-γ+ versus unstimulated Tem cells 
(Figure 2B), stimulated DENV IFN-γ+ versus unstimulated Tem-
ra cells (Figure 2C), unstimulated Tem versus Temra cells (Figure 
2D), and stimulated DENV IFN-γ+ Tem versus Temra cells (Figure 
2E). DE genes that resulted from these comparisons can be found 
in Supplemental Table 2. As expected, IFNG and many genes 
associated with activation and effector functions, such as CD69, 
CD160, CRTAM, SLAMF7, TNFRSF9, TNF, CCL3, CCL4, and 
GZMB, were upregulated in both DENV IFN-γ+ Tem and Temra 
cells (Figure 2, B and C, and Supplemental Table 2). Additionally, 
the expression of several costimulatory molecules, such as CTLA4 
and TNFSF14, as well as transcription factors such as EGR1, EGR2, 
EGR3, IRF4, and IRF8 was also increased in DENV IFN-γ+ Tem and 
Temra cells (Figure 2, B and C, and Supplemental Table 2). Since 
CD8 MP–stimulated IFN-γ– CD8+ T cell subsets were exposed to 
the DENV-derived epitopes similarly but did not respond to stimu-
lation, they could serve as another transcriptomic baseline in addi-
tion to unstimulated CD8+ T cell subsets. Therefore, we analyzed 
the DE genes between stimulated DENV IFN-γ+ versus stimulated 
IFN-γ– Tem cells as well as stimulated DENV IFN-γ+ versus stimu-
lated IFN-γ– Temra cells. Using this approach, 515 and 767 DE genes 
were identified by Tem and Temra comparisons, respectively (Sup-
possible that some unique molecular profiles might be associated 
with CD8+ Temra cells that are virus-specific and activated by cog-
nate antigens. Indeed, previous studies have compared the gene 
expression profiles and phenotypic attributes of human CD4 + T 
cell subsets and identified unique characteristics of CD4+ Temra 
cells (33, 34). A subset of CD4+ Temra cells has a highly specialized 
gene expression program and acquires the expression of cytotoxic 
molecules (33, 34), highlighting the general concept that T cell dif-
ferentiation can result in downregulation of “irrelevant” programs 
and/or acquisition of new or enriched gene expression programs. 
However, whether the differentiation of CD8+ Temra cells also 
results in similar gene expression patterns is not known.
In this study, we isolated and systematically characterized 
the immune signatures of DENV-specific CD8+ T cell subsets 
after stimulation with DENV epitopes. Our data show that 
DENV-specific CD8+ T cells predominantly consist of Tem and 
Temra cells, which upregulated the expression of gene modules 
associated with activation, costimulation, and effector func-
tions. The gene expression patterns of DENV-specific CD8+ T 
cells, especially Temra cells, are associated with relatively nar-
row transcriptional responses, suggesting that the differentia-
tion of antigen-specific CD8+ T cell subsets is associated with a 
focused and specialized approach.
Results
DENV-specific CD8+ T cells are predominantly Tem and Temra. 
To investigate the phenotypic and functional characteristics of 
DENV-specific CD8+ T cells, we focused on cells identified by the 
production of IFN-γ after stimulation with a previously defined 
pool of over 268 CD8 DENV epitopes (35), which allows for broad 
coverage of DENV responses, irrespective of HLA type and DENV 
serotype, and is referred to hereafter as the DENV megapool (CD8 
MP). This strategy was put in place based on previous observations 
that indicated that the majority of DENV-specific CD8+ T cells are 
strong producers of IFN-γ and thus could be detected ex vivo (19).
A series of previous studies from our group characterized 
DENV-specific CD8+ T cell responses in the context of natural 
immunity in populations heavily exposed to DENV (18, 19, 35). 
Here, following a similar approach, plasma samples from nor-
mal blood donors from the general hyperendemic population of 
the Colombo region in Sri Lanka were screened for high neu-
tralizing titers against multiple DENV serotype, reflective of 
previous multiple DENV infections. PBMCs from donors that 
had been infected with DENV multiple times were stimulated 
with the DENV megapool, and the memory phenotype of these 
DENV-specific CD8+ T cells was determined by the expression 
of the commonly used memory markers CD45RA and CCR7. 
Gating strategies and FACS profiles for a representative donor 
are shown in Figure 1A.
In a total of 6 donors analyzed, the frequency of IFN-γ+ CD8+ 
T cells ranged from 0.05% to 5.19% with a median value of 0.36% 
after unstimulated control responses were subtracted (Figure 1B). 
This relatively wide range is consistent with previous results (35), 
and might reflect variations in the previous infection history and 
time from infection, which is unknown for the blood bank donors 
analyzed in this study. While a prominent naive T (Tn) cell pop-
ulation was readily detectable among unstimulated IFN-γ– CD8+ 
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tor ZEB2 and several killer cell immunoglobulin-like receptors 
(KIRs), including inhibitory KIR2DL1, KIR2DL3, KIR3DL1, and 
KIR3DL2 and activating KIR2DS4 (Figure 2D and Supplemental 
Table 2), which bind to HLA-C2, HLA-C1, HLA-A/B with Bw4 epi-
tope, HLA-A, and HLA-C/A, respectively (36). This suggests that 
CD8+ Temra cells may resemble natural killer (NK) cells and have 
more specialized cytotoxic functions than Tem cells. Moreover, 
although the number of differentially expressed KIRs was reduced, 
the expression level of KIR2DL3 and KIR3DL1 was also higher in 
DENV IFN-γ+ Temra by comparison with DENV IFN-γ+ Tem cells 
(Figure 2E and Supplemental Table 2). Interestingly, Tem cells 
had approximately 2.5-fold more upregulated genes by compari-
son with Temra cells (215 vs. 85 genes; Figure 2D), suggesting that 
CD8+ Temra cells have a more focused gene expression pattern 
plemental Figure 2, A and B). Notably, over 52% (270 genes) of the 
Tem DE genes and 60% (464 genes) of the Temra DE genes were 
also detected by stimulated DENV IFN-γ+ versus unstimulated 
comparisons presented in Figure 2, B and C, and Supplemental 
Table 2 (Supplemental Figure 2, A and B). Moreover, the overlap-
ping genes include genes such as IFNG, CD69, CRTAM, SLAMF7, 
TNFRSF9, TNF, CCL3, CCL4, GZMB, CTLA4, EGR1, EGR2, EGR3, 
IRF4, and IRF8 as described above (Supplemental Figure 2, C 
and D, and Supplemental Table 3). Moreover, the fold changes of 
these overlapping genes were highly correlated between these two 
approaches (Supplemental Figure 2, C and D).
We next identified differentially expressed genes between 
unstimulated Tem and unstimulated Temra cells and found that 
Temra cells had enhanced expression of the transcription fac-
Figure 1. DENV-specific CD8+ T cells are predominantly Tem and Temra cells. Human PBMCs isolated from donors that had been infected with DENV 
multiple times were stimulated with DENV CD8+ T cell megapool, and DENV-specific CD8+ T cells were identified by the production of IFN-γ. (A) Gating 
strategy to identify and sort DENV-specific CD8+ Tem and Temra cells. (B) Flow cytometry plots (top) and bar graph (bottom) show the production of IFN-γ 
by CD8+ T cells (n = 6). (C) Flow cytometry plots (top) and bar graphs (bottom) show the expression of CD45RA and CCR7 by unstimulated IFN-γ– or DENV 
IFN-γ+ CD8+ T cells (n = 6). Error bars show median with interquartile range.
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3-fold change and likely reflected antigen-driven differentiation 
resulting in selective expression of fewer genes.
Gene ontology (GO) annotations indicated that DE genes upreg-
ulated in DENV IFN-γ+ Tem and Temra cells by comparison with 
than their Tem counterpart. This effect was even more apparent 
when DENV IFN-γ+ Tem and Temra cells were examined, as 300 
and 104 genes were upregulated in DENV IFN-γ+ Tem and Temra 
cells, respectively (Figure 2E), which resulted in an approximately 
Figure 2. Gene expression profiles of unstimulated and DENV IFN-γ+ 
CD8+ Tem and Temra cells. (A) PCA analysis of gene expression data of 
unstimulated and DENV IFN-γ+ CD8+ Tem and Temra cells (n = 6). (B–E) 
Volcano plots show log2 fold change versus –log10 adjusted P value (Padj) 
for the comparison between DENV IFN-γ+ Tem and unstimulated Tem (B), 
DENV IFN-γ+ Temra and unstimulated Temra (C), unstimulated Tem and 
unstimulated Temra (D), and DENV IFN-γ+ Tem and DENV IFN-γ+ Temra (E). 
The subset of genes with log2 fold change greater than 1 or less than –1 and 
adjusted P value less than 0.05 are considered significant and indicated 
by dotted lines. (F) Venn diagrams show the distribution of the 85 and 104 
genes upregulated in unstimulated Temra and DENV IFN-γ+ Temra by com-
parison with unstimulated Tem and DENV IFN-γ+ Tem cells, respectively, as 
shown in D and E.
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DENV IFN-γ+ Temra by comparison with unstimulated Tem and 
DENV IFN-γ+ Tem cells, respectively, we found that only 6 genes, 
including KIR2DL3 and KIR3DL1, were shared by these 2 lists 
of DE genes. In contrast, 79 genes were found to be specific for 
unstimulated Temra cells, whereas 98 were specific for DENV-spe-
cific Temra cells (Figure 2F and Supplemental Table 4). Unstimu-
lated Temra cells had higher expression of genes including CCL3, 
GNLY, IFNG, and ZEB2 than unstimulated Tem cells, suggesting 
that CD8+ Temra cells may be more activated than Tem cells at 
baseline without stimulation. In contrast, DENV IFN-γ+ Temra 
their unstimulated counterparts were associated with cytokine 
responses and metabolic processes (Supplemental Figure 3, A and 
B). DE genes upregulated in unstimulated Temra cells by compar-
ison with unstimulated Tem cells were associated with immune 
response regulation and cellular defense (Supplemental Figure 3C). 
DE genes upregulated in unstimulated Tem cells by comparison with 
unstimulated Temra cells and DE genes between DENV IFN-γ+ Tem 
and Temra cells were not significantly associated with any GO terms.
For Figure 2, D and E, by applying a Venn diagram approach 
to the 85 and 104 genes upregulated in unstimulated Temra and 
Figure 3. Identification of gene modules that can discriminate between unstimulated and DENV IFN-γ+ CD8+ Tem and Temra cells. (A) Schematic 
depicting the strategy for coexpression and clustering analysis. Module significance was assessed by comparison of the module eigengene values between 
DENV IFN-γ+ Tem and unstimulated Tem, DENV IFN-γ+ Temra and unstimulated Temra, unstimulated Tem and unstimulated Temra, and DENV IFN-γ+ Tem 
and DENV IFN-γ+ Temra cells. (B) Heatmap shows the Z-transformed expression values of the 360 differentially expressed (DE) genes contained by the 12 
significant modules. Selected genes from each module are highlighted.
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cells did not have higher expression of these genes than DENV 
IFN-γ+ Tem cells but upregulated genes such as IL2RG, which is 
referred to as the common γ chain and is a cytokine receptor sub-
unit shared by IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 receptors.
Identifying gene modules that can discriminate between different 
CD8+ T cell populations. The data presented above suggest that 
CD8+ Temra cells have a more focused and selective pattern of 
gene expression than their Tem counterpart; this finding is more 
pronounced in antigen-specific T cells. We reasoned that this 
might be reflective of the activation of specific gene modules, 
encompassing genes that are coordinately expressed in the dif-
ferent T cell subsets. Accordingly, to better understand the bio-
logical functions associated with those DE genes, we performed 
weighted gene coexpression network analysis (WGCNA) (37, 38). 
Figure 3A depicts the analytic strategy. Briefly, we filtered out 
low-expressed genes with a median transcripts per million (TPM) 
value of less than 10 in all of the 4 cell populations. We identified 
12 gene modules that were associated with statistically significant 
differences in least 1 of the 4 pairwise comparisons. The associat-
ed P values and the number of genes in each module are listed in 
Table 1. These 12 gene modules contained a total of 360 DE genes, 
which are listed in Supplemental Table 5 and were visualized on a 
heatmap as shown in Figure 3B.
We observed that there were 7 and 4 gene modules that could 
significantly distinguish DENV IFN-γ+ Tem and Temra cells from 
their unstimulated counterparts, respectively, and that 2 clusters 
(blue and magenta) were significant in both comparisons (Table 
1). The blue, yellow, purple, tan, turquoise, and dark gray mod-
ules mainly discriminate between unstimulated and DENV IFN-γ+ 
Tem and/or Temra cells and contained activation- and effector -
-associated genes such as CCL4, TNFRSF9 (encodes CD137), 
CCL3, IFNG, GZMB, CRTAM, TNF, LAG3, NFKBIZ, and HAVCR2 
(encodes Tim-3). Additionally, several transcription factors such as 
BCL2, ID2, IRF8, and IRF4 and genes involved in T cell migration 
such as SLAMF7 and S1PR2 were also found in these clusters.
We found that the blue, tan, magenta, salmon, orange, and 
pink modules were statistically distinct between unstimulated 
Tem and Temra cells when these 2 
populations were compared direct-
ly (Table 1). Notably, the salmon 
and pink modules were statistically 
significant only in this comparison 
and contained genes such as CD28 
and CD83, which are involved in 
T cell activation. In contrast, the 
gray, green, and black modules dis-
tinguished DENV IFN-γ+ Tem and 
Temra cells (Table 1), and DENV 
IFN-γ+ Temra cells largely down-
regulated the genes contained 
in the green and black modules 
(Figure 3B). Thus, stimulation 
with DENV epitopes changes the 
differences between responding 
CD8+ Tem and Temra cells. These 
data further emphasize that a cru-
cial difference between CD8+ Tem 
and Temra cells is the degree of selectivity in the pattern of gene 
expression, especially following antigen-specific stimulation.
Validation of differentially expressed genes by CyTOF. To vali-
date the mRNA expression signatures of unstimulated and DENV 
IFN-γ+ CD8+ Tem and Temra cells, we used an independent set 
of donors and performed cytometry by time-of-flight (CyTOF) 
analysis on selected DE genes that were contained in the gene 
modules identified in Figure 3 and for which antibodies were 
commercially available. Owing to limited antibody availability 
for the genes that could discriminate DENV IFN-γ+ Tem and Tem-
ra cells, most of the molecules analyzed in Figure 4 were upreg-
ulated in DENV IFN-γ+ Tem and Temra cells as compared with 
their unstimulated counterparts. Consistent with gene expression 
analysis, the protein expression patterns largely matched what we 
observed at the gene expression level. By comparison with their 
unstimulated counterparts, DENV IFN-γ+ Tem and Temra cells 
had higher expression of activation and effector molecules such 
as CCL3/CCL4 (the anti-CCL3 antibody used cross-reacts with 
CCL4), CD69, CRTAM, IFN-γ, and TNF-α, costimulatory mole-
cules such as CLTA4, ICOS, and LIGHT (encoded by TNFSF14), 
transcription factors including IRF4 and IRF8, and signaling lym-
phocytic activation molecule family member 7 (SLAMF7), which 
is involved in lymphocyte activation, inhibition, differentiation, 
and adhesion (Figure 4). The protein expression level of KIR2DL3 
detected by CyTOF was generally low (Figure 4). There was no 
significant difference between DENV IFN-γ+ Tem/Temra and 
unstimulated Tem/Temra cells in terms of their KIR2DL3 expres-
sion at the protein level, and we only observed a subtle but signif-
icant difference between DENV IFN-γ+ Temra and DENV IFN-γ+ 
Tem cells (Figure 4). Two-way ANOVA analyses confirmed the 
hypothesis that markers on the DENV IFN-γ+ subsets had higher 
protein expression compared with their unstimulated counter-
parts with a P value of 0.0013 and 0.0044 for Tem and Temra 
cells, respectively. The bar graphs in Figure 4 show the contri-
bution of individual markers to this difference and indicate the 
P values specific to each marker (comparisons used the 2-tailed 
Wilcoxon test, not corrected for multiple comparisons in order 
Table 1. P values for each gene module for each comparison and the number of genes within each 
gene module
DENV IFN-γ+ Tem vs. 
unstimulated Tem
DENV IFN-γ+ Temra vs. 
unstimulated Temra
Unstimulated Tem vs. 
unstimulated Temra
DENV IFN-γ+ Tem vs.  
DENV IFN-γ+ Temra
No. of  
genes
Blue 0.000 0.001 0.035 0.118 209
Yellow 0.001 0.128 0.387 0.054 4
Purple 0.003 0.325 0.161 0.274 14
Tan 0.004 0.253 0.039 0.331 13
Turquoise 0.007 0.604 0.173 0.108 3
Dark gray 0.963 0.030 0.510 0.049 2
Magenta 0.001 0.012 0.018 0.158 6
Salmon 0.059 0.585 0.030 0.339 14
Orange 0.037 0.435 0.041 0.462 9
Pink 0.899 0.614 0.042 0.520 22
Green 0.770 0.313 0.305 0.032 40
Black 0.613 0.008 0.585 0.036 24
Statistical significance was determined by 2-tailed paired Student’s t test.
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to best show the contribution of different markers to the over-
all results). Based on Šidák’s multiple- comparisons test, TNF-α, 
IFN-γ, and CCL3/CCL4 reached statistical significance with an 
adjusted P value of 0.0059, <0.0001, and <0.0001, respectively. 
Taken together, the signatures identified based on mRNA expres-
sion were largely also detectable at the protein level.
We next performed single-cell analysis of CyTOF data to 
investigate potentially interesting dynamics of unique CD8+ T 
cell subsets. The expression levels of 32 surface and intracellular 
molecules by CD8+ T cells were measured simultaneously, and 
2-dimensional maps of the resulting high-dimensional data were 
generated by visualization of stochastic neighbor embedding 
(viSNE) (39). While Tn cells were arranged largely in one area 
of the map, Tcm and especially Tem and Temra cells displayed 
a broader distribution and were grouped into several distinct 
islands, suggesting that these memory subsets were heteroge-
neous and could be further divided into dynamic subpopulations 
(Figure 5A). Notably, IFN-γ+ DENV-specific CD8+ T cells formed a 
Figure 4. Validation of differentially expressed genes at 
the protein level. Bar graphs show gene expression values 
in counts normalized by sequencing depth calculated by the 
DESeq2 package (upper panels, n = 6) and protein expression 
values in mean fluorescence intensity (MFI) (lower panels, n 
= 7) for various molecules in unstimulated and DENV IFN-γ+ 
CD8+ Tem and Temra cells. Error bars show median with inter-
quartile range. For gene expression values, a pseudocount of 
0.5 was added to allow for plotting in log scale, and statistical 
significance was determined by DESeq2 using Wald test and 
then adjusted for multiple testing using the Benjamini- 
Hochberg procedure; *P < 0.05, **P < 0.01, ***P < 0.001. For 
protein expression values, statistical significance was deter-
mined by 2-tailed Wilcoxon test; *P < 0.05. For KIR2DL3, the 
P value for the protein level comparison between DENV IFN-γ+ 
Tem and DENV IFN-γ+ Temra cells was 0.0312.
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Figure 5. Single-cell analysis of high-dimensional CyTOF data reveals dynamics of CD8+ T cell subsets. viSNE analysis arranged cells along tSNE1 and 
tSNE2 axes based on the expression of 32 proteins (n = 7). (A) Manually gated Tn, Tcm, Tem, and Temra populations were colored and overlaid on the 
viSNE map of total CD8+ T cells for each donor. Gated population represented IFN-γ+ CD8+ T cells. (B) viSNE plots show the expression of CCL3, CD69, 
CTLA4, TNF-α, IRF4, and IRF8 per cell for each donor. Gated population represented IFN-γ+ CD8+ T cells.
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and Temra cells showed preferential usage of certain TRBV genes. 
For example, TRBV7-9 was expanded and overrepresented in both 
DENV-specific Tem and Temra cells in donor GS1149, whereas 
TRBV7-8 was predominantly used by DENV-specific CD8+ T cells, 
especially Tem cells, in donor GS1180 (Figure 6C). Intriguingly, 
in donor GS1188, TRBV9 was the single most predominant TRBV 
segment in DENV-specific Temra cells, whereas DENV-specific 
Tem cells were less biased, with TRBV4-3 being the most overrep-
resented TRBV segment in those cells (Figure 6C). Taken togeth-
er, these data suggest that CD8+ Temra cells tend to have more 
biased TCR repertoires than Tem cells and that DENV-specific 
CD8+ Tem and Temra cells show both common and distinct TRBV 
gene usage in their TCR repertoires.
Discussion
This study is, to our knowledge, the first systematic analysis of 
isolated human virus-specific CD8+ memory T cell subsets, name-
ly Tem and Temra cells. The current study built on previously 
published results implicating that CD8+ Tem and Temra cells are 
important in protection against viral pathogens and further char-
acterized these CD8+ T cell subsets at the transcriptomic level, 
but it does not directly address protection. Our data show that the 
transcriptional profiles of antigen-specific CD8+ T cell subsets are 
highly different from those of unstimulated ones, thus highlight-
ing the value of our approach and demonstrating that sequencing 
of bulk non–antigen-specific T cells alone will miss important 
determinants of the molecular programs. We further found that 
the differentiation of DENV-specific CD8+ T cell subsets, espe-
cially Temra cells, is associated with narrowing the transcription-
al program and TCR repertoires program. The secondary donors 
studied here were from endemic areas and had been infected 
with DENV multiple times; therefore, it is expected that they had 
developed, at least to some extent, natural immunity from severe 
disease (43). These results could help guide the development of 
effective vaccines by providing a benchmark that vaccine-specific 
response could aim to replicate. According to the current study, 
a vaccine that elicits a strong CD8+ Temra response and specifi-
cally activates molecules such as CCL3/CCL4, CD69, CRTAM, 
IFN-γ, TNF-α, CTLA4, ICOS, LIGHT, IRF4, IRF8, SLAMF7, and 
KIR2DL3 would be expected to be of particular interest. More-
over, to our knowledge, this is the first transcriptomic profiling 
of isolated human antigen-specific CD8+ T cell subsets following 
stimulation with cognate antigen. The results have general impli-
cations for our understanding of the differentiation and activity of 
CD8+ T cell subsets.
The current study provides several insights into the gene 
expression profiles of unstimulated bulk versus DENV-specific 
CD8+ T cell subsets. Our data systematically characterized the 
immune signatures of DENV-specific CD8+ T cell subsets, and the 
expression of numerous genes was confirmed at the protein lev-
el by cytometry by time-of-flight (CyTOF). Collectively, the data 
indicate that CD8+ Temra cells have a more focused and selective 
gene expression pattern than Tem cells.
First, we showed that the majority of IFN-γ–producing 
CD8+ T cells in response to DENV epitopes display a Tem or 
Temra phenotype. Second, we identified genes that are upreg-
ulated in both DENV-specific Tem and Temra cell populations 
distinct island and mainly consisted of Tem and/or Temra subsets 
with the relative proportion of these 2 subsets varying between 
donors (Figure 5A). Furthermore, within the island of IFN-γ+ cells, 
some molecules, such as CCL3 and CD69, showed clustered 
expression, while others, such as CTLA4, TNF-α, IRF4, and IRF8, 
displayed a gradient or mixture of expression (Figure 5B). Taken 
together, this approach revealed dynamic and intermediate states 
of CD8+ T cell activation.
DENV-specific Tem and Temra cells are associated with preferen-
tial TRBV gene usage. Previous studies show that CD4+ Temra cells 
with a cytotoxic phenotype have more restricted T cell receptor 
(TCR) repertoires compared with CD4+ Tem cells (33, 34). Based 
on these results and on the general gene expression patterns 
described above, we predicted that CD8+ Temra cells would also 
have a more restricted TCR repertoire than their Tem counter-
part. To test this hypothesis, we next investigated whether unstim-
ulated IFN-γ– as well as DENV IFN-γ+ CD8+ Tem and Temra cells 
also had distinct TCR repertoire characteristics. To this end, we 
extracted TCR β chain (TRB) CDR3 repertoires from the RNA-Seq 
data of sorted unstimulated IFN-γ– as well as DENV IFN-γ+ CD8+ 
Tem and Temra cells using MiXCR software (40, 41).
We observed that the TRB repertoire of unstimulated IFN-γ– 
CD8+ Temra cells is less diverse than that of unstimulated CD8+ 
Tem cells; however, this difference did not reach statistical signif-
icance (adjusted P value = 0.1014 with Dunn’s multiple-compari-
sons test; Figure 6A). Likewise, there was a nonsignificant trend 
(adjusted P value = 0.1014 with Dunn’s multiple-comparisons 
test; Figure 6A) for DENV-specific CD8+ Tem cells to have less 
diverse TRB repertoires compared with unstimulated Tem cells. 
The diversity of DENV IFN-γ+ Temra cells was similar to that of 
unstimulated Temra cells. Additionally, no significant difference 
was observed between DENV-specific CD8+ Tem and Temra cells 
(Figure 6A). The overall P value determined by Friedman test was 
0.0228, and unstimulated Tem versus DENV IFN-γ+ Tem and 
unstimulated Tem versus unstimulated Temra were the 2 biggest 
contributors to this overall significance. Thus, these data may sug-
gest that Tem cells may undergo clonal expansion in response to 
DENV antigens and that the Temra subset may mainly consist of 
highly clonally expanded cells.
We next evaluated the overlap of TRB repertoires by com-
puting the normalized number of shared clonotypes using CDR3 
amino acid sequences as previously described (42). This analysis 
revealed that the degree of overlap was higher between DENV-spe-
cific and unstimulated Temra cells compared with DENV IFN-γ+ 
and unstimulated Tem cells (Figure 6B). Nevertheless, the highest 
level of overlap was observed between DENV IFN-γ+ CD8+ Tem 
and Temra cells (Figure 6B), indicating that certain DENV CD8+ 
T cell epitopes are likely recognized by both Tem and Temra cells 
that share the same TCR.
Furthermore, we performed analysis of TRBV segment usage 
that revealed large variations between individual donors (Figure 
6C and Supplemental Table 6), which was in line with the diverse 
MHC class I alleles of the cohort (Supplemental Table 1). Temra 
cells tend to have a narrower distribution in their TCR repertoires 
than Tem cells, as Temra cell TCR repertoires consisted of fewer 
segments than their Tem counterparts in 5 of the 6 tested donors 
(Figure 6C). Notably, in some donors DENV-specific CD8+ Tem 
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modules are associated with activation, costimulation, and 
effector functions, as they contain genes such as CCL3, CCL4, 
CD69, CRTAM, CTLA4, ICOS, IFNG, IRF4, IRF8, SLAMF7, 
TNF, and TNFSF14. Please note that our results do not point 
following stimulation with DENV-specific epitopes, in compar-
ison with their unstimulated counterparts. Coexpression and 
clustering analysis revealed gene modules that are upregulat-
ed in DENV-specific CD8+ Tem and Temra cells. These gene 
Figure 6. DENV-specific Tem and Temra cells have limited TCR repertoires and show preferential TRBV gene usage. (A) Dot plot shows the inverse 
Simpson index of the TCR repertoires of unstimulated and DENV IFN-γ+ Tem and Temra cells (n = 6). Note that only 5 data points were discernible for the 
unstimulated Tem group, as 2 of the data points had almost identical values. The overall P value determined by nonparametric Friedman test was 0.0228. 
Statistical significance between groups was determined by Dunn’s multiple-comparisons test, and adjusted P values are indicated in the figure. (B) Heat-
map shows the normalized number of clonotypes with identical CDR3 amino acid sequences shared between CD8+ T cell subsets. (C) Bar graphs show the 
percentages of various TRBV segments within each population for each individual donor (n = 6).
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sion. Nevertheless, the expression of KIR2DL3 at the protein level 
measured by CyTOF, with the anti-KIR2DL3 used in this study, 
was generally low, and we only observed a subtle but significant 
different between DENV Temra and DENV Tem cells. We also 
note that a few donors displayed higher KIR2DL3 gene expression 
levels than the other donors. Given the standard deviation of the 
mean for these 2 groups, the differential expression of KIR2DL3 
at the mRNA level between unstimulated Tem and Temra cells, 
and between DENV-specific Tem and DENV-specific Temra 
cells, should be interpreted with caution. Additionally, the dif-
ference in protein expression level of KIR2DL3 between unstim-
ulated Tem and Temra cells was not significant, which was incon-
sistent with the RNA-Seq data. While protein and RNA levels are 
in general correlated, there are also instances such as BCL-6 (46) 
in which there is a lack of concordance between mRNA and pro-
tein expression. Likewise, protein expression levels of KIR2DL3 
between DENV-specific Temra and DENV-specific Tem cells 
are significantly different, but the difference is very subtle. For 
this reason, the difference in KIR2DL3 expression should also be 
interpreted with caution. Although KIRs have been implicated in 
dengue disease severity (47–49), whether the expression of KIRs 
on CD8+ T cells has any functional role in anti-DENV immunity 
warrants further investigation.
One distinctive aspect of this study is the integration of tran-
scriptional and phenotypic profiling with TCR analysis. Our anal-
ysis of TRB repertoire overlap between CD8+ T cell subsets reveals 
that DENV-specific CD8+ Tem and Temra cells have the highest 
degree of overlap. Thus, it is possible that some DENV-specific 
Tem and Temra cells may share certain CDR3 sequences as pre-
viously observed for HCMV-specific CD4+ Tem and Temra cells 
(50). Since Temra cells also have a more specialized gene expres-
sion profile, we speculate that some Temra cells may derive from 
Tem cell clones and then undergo clonal expansion and differen-
tiation. We further analyzed the usage of TRBV segments in indi-
vidual donors and observed that DENV-specific CD8+ Tem and 
Temra cells have preferential usage of certain TRBV genes partic-
ularly in some of the donors. Because of the variation in MHC class 
I alleles between donors in the cohort, we did not observe a single 
TRBV segment that is overrepresented in 2 or more donors. Nev-
ertheless, 2 TRBV7 subgroup members, TRBV7-9 and TRBV7-8, 
are preferentially used by DENV-specific Tem and Temra cells in 
donors GS1149 and GS1180, respectively, and the 2 donors share 
2 MHC class I alleles, HLA-B*35:03 and HLA-C*04:01. A few 
TRBV segments, including TRBV11-2, TRBV9, and TRBV12-3/4, 
have been reported to be commonly represented in HLA-A*11:01–
restricted CD8+ T cells that are specific for the nonstructural 
protein epitope NS3133 variants derived from DENV1, DENV3, 
and DENV4 (51). Notably, TRBV9 was also overrepresented in 
DENV-specific Tem and, to a much larger extent, Temra cells in 
donor GS1188, who possessed the HLA-A*11:01 allele. Thus, this 
study extends previous findings and further reveals the similarities 
and differences between DENV-specific Tem and Temra subsets 
in terms of their TCR features.
As total DENV-specific IFN-γ+ CD8+ T cell subsets were sorted 
and analyzed in the current study, one cannot rule out the possi-
bility that protection against DENV is mediated by a subpopu-
lation(s) harboring a specific TCR(s) instead of being mediated 
to a single gene/factor that may determine the generation of 
CD8+ Tem or Temra cells. Additionally, the differentiation of 
CD8+ Tem and Temra cells is not unique to DENV infection, 
and we do not know whether the differentially expressed genes 
observed in the current study would also apply to other viruses. 
Third, we identified 2 sets of gene modules that distinguish 
Tem from Temra cells, one for unstimulated Tem and Temra 
cells, one for DENV-specific Tem and Temra cells. By compar-
ing Tem and Temra cells directly, we found that more genes are 
expressed at higher levels in Tem cells than in Temra cells. In 
contrast, Temra cells have higher expression of several killer 
cell immunoglobulin -like receptors (KIRs), including KIR2DL3, 
suggesting that Temra cells have more specialized phenotype 
and function. Finally, we discovered that DENV-specific CD8+ 
Tem and Temra cells displayed preferential TRBV gene usage, 
indicating clonal expansion of certain T cell clones.
Previous studies by Chandele et al. show that HLA-DR+CD38+ 
and HLA-DR–CD38+ effector CD8+ T cell subsets expand during 
the acute febrile phase of DENV infection, and these effector CD8+ 
T cells, especially those that are HLA-DR+CD38+, are highly activated 
and upregulate genes associated with T cell activation, prolifera-
tion, cytotoxicity, and migration (27). In this study, we further iso-
lated DENV-specific CD8+ T cells via their production of IFN-γ in 
response to a comprehensive pool of CD8+ T cell epitopes derived 
from DENV. Moreover, we identified and analyzed DENV-specific 
Tem and Temra cells separately. Although our samples were collect-
ed from secondary DENV-infected donors who were healthy at the 
time of sample collection, we found that DENV-specific CD8+ Tem 
and/or Temra cells still upregulated many of the genes reported 
by Chandele et al., such as XCL1, GZMB, CTLA4, HAVCR2, LAG3, 
and CD160, suggesting that DENV-specific CD8+ T cells may 
maintain an activated differentiated state even at convalescent 
stage in donors that have been infected with DENV multiple times. 
Thus, these cells may respond rapidly and exert effector functions 
on DENV reinfections.
It has been previously shown that CD4+ Temra cells are het-
erogeneous and that GPR56-expressing Temra subpopulations 
have a specialized gene expression program characterized by 
the upregulation of cytotoxic molecules (33, 34). Consistent with 
these previous findings on CD4+ Temra cells, this study shows 
that CD8+ Temra cells also display a more focused and specialized 
gene expression profile than Tem cells. Pairwise comparisons 
between unstimulated Tem and Temra cells as well as between 
DENV- specific Tem and Temra cells reveal that the number of 
genes upregulated in Tem cells is much greater than that upreg-
ulated in Temra cells. It is likely that many active genes gradu-
ally reduce expression in Temra cells as they progress toward a 
more specialized differentiation state. In line with this notion, we 
found that CD8+ Temra cells have enhanced expression of sev-
eral KIRs at the mRNA level, which is consistent with a previous 
report (44). Although KIRs are primarily expressed on NK cells, 
terminally differentiated CD8+ T cells can acquire the expression 
of KIRs (45). Furthermore, most KIR-expressing CD8+ T cells 
display a limited KIR repertoire (45). Notably, the DENV-specific 
Temra cell population only upregulate 2 (KIR2DL3 and KIR3DL1) 
of the 5 KIRs that are upregulated by their unstimulated counter-
part, likely manifesting extensive antigen-driven clonal expan-
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determined by flow cytometry–based neutralization assay (54) and are 
referred to as secondary DENV infection donors.
IFN-γ capture assay and cell sorting for RNA-Seq. Human PBMCs 
were rested overnight at 37°C in RPMI 1640 medium (catalog RP-21, 
Omega Scientific Inc.) supplemented with 5% human serum (catalog 
100-512, Gemini Bio-Products), 2 mM l-alanyl-l-glutamine (Gluta-
MAX-I, catalog 35050061, Thermo Fisher Scientific), 100 U/ml pen-
icillin, and 100 μg/ml streptomycin (catalog 400-109, Gemini Bio- 
Products) and subsequently stimulated with DENV megapool (CD8 
MP) (1 μg/ml for individual peptides) or left unstimulated for 3 hours 
at 37°C. The generation of the CD8 MP was previously described 
(19). Briefly, the CD8 MP consisted of 268 epitopes that were select-
ed to account for 90% of the IFN-γ response in both Sri Lankan and 
Nicaraguan cohorts (18, 19, 35). The 268 peptides were pooled, lyo-
philized, and resuspended (1 mg/ml for individual peptides) to form 
a master mix, which was then used for stimulation. IFN-γ–producing 
cells were labeled using an IFN-γ Secretion Assay – Detection Kit (cat-
alog 130-054-202, Miltenyi Biotec) according to the manufacturer’s 
instructions. Subsequently, PBMCs were stained with anti–human 
CD3, CD4, CD8, CD14, CD19, CD45RA, and CCR7 (see Supple-
mental Table 7 for antibody details). CD8+ IFN-γ– and IFN-γ+ naive 
(CD14–CD19–CD3+CD4–CD8+CD45RA+CCR7+), Tcm (CD14–CD19–
CD3+CD4–CD8+CD45RA–CCR7+), Tem (CD14–CD19–CD3+CD4–
CD8+CD45RA–CCR7–), and Temra (CD14–CD19–CD3+CD4–CD8+ 
CD45RA+CCR7–) cells were sorted into 8 μl of lysis buffer consisting 
of Triton X-100 (Sigma-Aldrich), recombinant ribonuclease inhibitor 
(Takara), and dNTP mix (Thermo Fisher Scientific).
HLA-B*35:01 tetramer staining. The source of the tetramers used 
in this study and tetramer staining were described previously (19). 
Briefly, tetramers incorporating eight HLA-B*35:01–restricted DENV 
epitopes contained in the CD8 MP (HPGAGKTKRY, TPEGIIPTLF, 
LPVWLAYKVA, TPEGIIPALF, TPEGIIPSMF, VATTFVTPM, IAN-
QATVLM, and FTMRHKKATY) were provided by the NIH Tetramer 
Core Facility. The 8 tetramers were pooled and used to stain PBMCs at 
a 1:50 dilution for 90 minutes at room temperature. Additional pheno-
typic markers were added into the mixture after 1 hour. Samples were 
then acquired using an LSR II flow cytometer (BD Biosciences) and 
analyzed using FlowJo (Tree Star).
Microscaled RNA-Seq. For each condition, 200 cells were collect-
ed at 4°C in 8 μl of lysis buffer composed by 0.2% Triton X-100, 2 U/
μl of recombinant RNase inhibitor (Clontech/Takara), 5 mM dNTP 
mix (Life Technologies) in a 0.2-ml PCR tube (MAXYMum Recov-
ery, Axygen). Right after sorting, tubes were vortexed at medium 
speed, spun for 5 minutes at more than 2000 g, and stored at –80°C 
until the completion of the whole set of samples. Four microliters of 
each sample was amplified following the Smart-seq2 protocol (55, 
56). Briefly, mRNA was captured using poly-dT oligonucleotides and 
directly reverse- transcribed into full-length cDNA using the described 
template- switching oligonucleotide (55, 56). cDNA was amplified by 
PCR for 18 cycles and purified using AMPure XP magnetic beads (0.9:1 
[vol/vol] ratio; Beckman Coulter). From this step, for each sample, 1 
ng of cDNA was used to prepare a standard Nextera XT sequencing 
library (Nextera XT DNA library prep kit and index kits, Illumina). 
Barcoded Illumina sequencing libraries (Nextera, Illumina) were gen-
erated using an automated platform (Biomek FXP, Beckman Coulter). 
Both whole-transcriptome amplification and sequencing library prepa-
rations were performed in a 96-well format to reduce assay-to-assay 
homogeneously by the entire DENV-specific IFN-γ+ CD8+ T cell 
populations. It would be interesting to investigate whether or not 
such subpopulations with a specific TCR would display a mainly 
Temra phenotype.
Our data showed that there was no significant difference 
between unstimulated Temra and DENV-specific Temra cells 
in terms of the diversity of their TCR repertoires. This might be 
partially due to the fact that the TCR repertoires of stimulated 
DENV-specific Temra cells might already be enriched in the 
unstimulated Temra population in those donors as they have been 
infected multiple times with DENV. While Temra cells might be 
an important component of the potent adaptive immune response 
against DENV, additional studies are needed to clarify the specific 
roles of this subset in protecting against DENV and address how 
this subset functionally compares with Tem cells during DENV 
infection. Clearly, the establishing of functional correlates of 
DENV-specific CD8+ T cell subsets is hampered by the fact that 
murine models of DENV infection are limited and that Temra cells 
are only defined in humans, not in mice. Additional insights would 
be provided by extensive investigation of the correlation between 
the activity of DENV-specific Tem and Temra cells during acute 
DENV infection and disease outcomes, which is beyond the scope 
of the current study.
One remaining issue is whether the magnitude of DENV- 
specific CD8+ T cell response correlates with neutralization anti-
body titers. Clearly, the number of data points in the current study 
is not suited to establish a meaningful correlation, but can be 
inspected for trends to be followed up in future studies. Although 
our study was not designed to address this question, based on 
the 6 donors used for RNA-Seq, we found that 3 of the 3 donors 
with a higher response magnitude (>0.3% IFN-γ+ CD8+ T cells in 
response to DENV epitopes) had a median neutralization antibody 
titer greater than 500. In contrast, only 1 of the 3 donors with a 
low response magnitude (<0.3% IFN-γ+ CD8+ T cells in response 
to DENV epitopes) had a median neutralization antibody titer 
greater than 500. Future studies are needed to investigate wheth-
er DENV-specific CD8+ T cell responses are correlated with neu-
tralizing antibody responses.
In summary, our data show that the differentiation program 
of human DENV-specific CD8+ T cell subsets, especially Temra 
cells, while being activated and polyfunctional, is associated with 
narrow transcriptional responses and TCR repertoires, and thus 
a more focused and specialized approach. These findings reveal 
immune signatures of human DENV-specific CD8+ Tem and Temra 
subsets and may have broad implications for understanding the 
differentiation of antigen-specific CD8+ T cell subsets.
Methods
Human blood samples. Blood samples from healthy adult blood donors 
of both sexes between the ages of 18 and 65 were collected anony-
mously by the National Blood Center, Ministry of Health, Colombo, 
Sri Lanka, between 2010 and 2016 and processed at the Genetech 
Research Institute as previously described (52). The details of the 
donors used in this study are listed in Supplemental Table 1.
Serology. DENV seropositivity was determined by anti-DENV IgG 
ELISA as previously described (53). Seropositive donors who experi-
enced multiple infections with more than one DENV serotype were 
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CyTOF. PBMCs were stimulated with DENV CD8+ T cell pep-
tide pool (1 μg/ml for individual peptides) or left unstimulated in 
the presence of brefeldin A (GolgiPlug, BD Biosciences) for 6 hours. 
Subsequently, CD8+ T cells were isolated from the PBMCs using a 
human CD8+ T cell isolation kit (Miltenyi Biotec) according to the 
manufacturer’s instructions. Isolated CD8+ T cells were then stained 
with the viability marker cisplatin followed by a surface antibody 
cocktail. Subsequently, cells were fixed in PBS with 2% paraformal-
dehyde overnight at 4°C. The following day, cells were stained with 
an intracellular/intranuclear antibody cocktail after fixation and 
permeabilization using the Foxp3/Transcription Factor Staining 
Buffer Set (eBioscience). Before sample acquisition, cellular DNA 
was labeled with Cell-ID Intercalator-Ir (Fluidigm). Samples were 
then acquired using a Helios mass cytometer (Fluidigm). Antibodies 
used in CyTOF are listed in Supplemental Table 8. Visualization of 
stochastic neighbor embedding (viSNE) analysis of CyTOF data was 
conducted using Cytobank (66).
TCR analysis. MiXCR v2.1.5 (40, 41) was used to extract TCR β 
chain CDR3 repertoires from RNA-Seq data of sorted T cell subsets. 
Subsequent TCR β chain diversity and repertoire overlap analyses 
were performed using the tcR R package v2.2.1.7 (67), and gene usage 
was analyzed using VDJtools v1.1.7 (68).
Data availability. The RNA-Seq data were deposited in the NCBI’s 
Gene Expression Omnibus (GEO) database under the accession code 
GSE116957 and ImmPort under the study number SDY 888.
Statistics. Two-tailed Mann-Whitney (unpaired), Wilcoxon 
(paired), Friedman (paired), or 2-way ANOVA test was used to deter-
mine statistical significance between groups using Prism software 
(GraphPad). Šidák’s and Dunn’s multiple-comparisons tests were per-
formed using Prism software. Statistical significance of gene modules 
was determined by 2-tailed paired Student’s t test.
Study approval. The institutional review boards of both the La 
Jolla Institute for Immunology and the Medical Faculty, University of 
Colombo (serving as the NIH-approved Institutional Review Board 
for Genetech), approved all protocols described in this study. Please 
note that Sri Lankan blood samples were discarded buffy coats from 
routine blood donations at the National Blood Center and thus were 
exempt from human subject review as suggested by the institutional 
review boards.
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complexity reads (DUST > 4) were removed from the BAM files. The 
alignment results were parsed via SAMtools (59) to generate SAM 
files. Read counts to each genomic feature were obtained with the 
htseq-count program (60) using the “union” option. After removal 
of absent features (zero counts in all samples), the raw counts were 
then imported to DESeq2 v1.16.1 to identify differentially expressed 
genes between groups (61). Paired DE analysis was performed using 
a multifactor design that includes the donor information as a term 
in the design formula in DESeq2, which accounts for differences 
between the donors. Wald test P values were adjusted for multiple 
testing using the Benjamini-Hochberg procedure (62), and genes 
with an adjusted P value less than 0.05 and a shrunken log2 fold 
change greater than 1 or less than –1 were considered significantly 
differentially expressed between groups.
Transcripts per kilobase million for a given genei in a given sample 
was calculated as follows: TPMi = 10
6 × (Ni / Li) / [Σj (Nj / Lj)], where Ni 
is the number of reads for genei, Li is the length of genei, and Σj (Nj / Lj) 
is the sum of the rate of reads per kilobase for all the genes present in 
the sample. Genes with a median TPM value less than 10 in all of the 4 
cell groups were excluded (63).
The Web tool Enrichr (http://amp.pharm.mssm.edu/Enrichr/) 
was used to perform gene ontology (GO) biological processes enrich-
ment analysis (64, 65). Fisher exact test was used to assess the signif-
icance of the enrichment, and biological processes with an adjusted P 
value less than 0.05 were considered significant.
Coexpression and clustering analysis. Weighted gene coexpression 
network analysis (WGCNA) was performed to identify sets of genes 
that share a similar expression pattern (37, 38). Genes with a median 
TPM value less than 10 in all of the 4 cell groups were excluded from 
the WGCNA analysis (63). A total of 31 coexpression modules were 
identified by WGCNA. The gene expression profile of a module was 
summarized by module eigengene, which is defined as the principal 
component of the module (37, 38). To determine which modules could 
discriminate between 2 given cell groups, we compared the module 
eigengene values between samples from each of the 2 given cell groups. 
Since each donor contributed 1 sample to each of the cell groups, we 
performed a paired t test and considered a P value of ≤0.05 as statis-
tically significant. To further enrich the selected modules with genes 
that have a high “discriminatory” power, only those genes identified in 
differential expression analyses were retained (for the cases in which 
the module achieved significance). In addition, only DE genes with 
high intramodular connectivity (membership ≥0.5) were included.
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